European Radiology

, Volume 14, Issue 11, pp 2125–2133 | Cite as

Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent

  • Laure S. Fournier
  • Charles Andre Cuenod
  • Cedric de Bazelaire
  • Nathalie Siauve
  • Christophe Rosty
  • Phuong Lan Tran
  • Guy Frija
  • Olivier Clement


Macromolecular contrast-enhanced functional CT was performed to characterize early perfusion changes in hepatocellular carcinoma (HCC). Fourteen rats with chemically induced primary liver tumors ranging pathologically from hyperplasia to HCC and 15 control rats were investigated. Two dynamic CT scans using an experimental macromolecular contrast agent were performed on a single slice 11 and 18 weeks after tumor induction followed by pathological examination. A deconvolution mathematical model was applied, yielding the hepatic perfusion index (HPI), mean transit time (MTT), liver distribution volume (LDV) and arterial, portal and total blood flows (FA, FP, FT). Analysis was performed on one slice per rat, containing overall two hyperplasia, six dysplasia and 15 HCC. On the first scans, HCC at an early pathological stage had a low FP (−30%, P=0.002) but a normal arterial-portal balance. On the scan contemporary to pathology, HCC perfusion parameters showed an inversion of the arterial-portal balance (HPI +212%, P<0.0001), with a high FA (+56%, P=0.002) and a low FP (−69%, P<0.0001). Sensitivity and specificity of detection of HCC by perfusion CT were high (87 and 80%) on late scans; but also on the earlier scans (86 and 65%), even though only one (7%) was visible to the eye. Perfusion-CT allowed early detection of HCC. This technique could contribute in the detection and characterization of liver lesions in clinical studies.


Angiogenesis Perfusion imaging Hepatocellular carcinoma Computed tomography Animal imaging 



L.S. Fournier was supported by a grant from the Fondation pour la Recherche Medicale.


  1. 1.
    Palma LD (1998) Diagnostic imaging and interventional therapy of hepatocellular carcinoma. Br J Radiol 711:808–818Google Scholar
  2. 2.
    Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, Zeuzem S (1999) Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol 94:3314–3319CrossRefPubMedGoogle Scholar
  3. 3.
    Ramsey WH, Wu GY (1995) Hepatocellular carcinoma: update on diagnosis and treatment. Dig Dis 13:81–91PubMedGoogle Scholar
  4. 4.
    Passe TJ, Bluemke DA, Siegelman SS (1997) Tumor angiogenesis: tutorial on implications for imaging. Radiology 203:593–600PubMedGoogle Scholar
  5. 5.
    Genecin P, Groszmann RJ (1991) Hepatic blood flow, measurement, and physiological regulation. In: Mcintyre N, Benhamou JP, Bircher J (eds) Oxford textbook of clinical hepatology. Oxford University, Oxford, pp 31–37Google Scholar
  6. 6.
    Williams GM, Gebhardt R, Sirma H, Stenback F (1993) Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine. Carcinogenesis 14:2149–2156PubMedGoogle Scholar
  7. 7.
    Cuenod C, Leconte I, Siauve N, Resten A, Dromain C, Poulet B, Frouin F, Clement O, Frija G (2001) Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 218:556–561PubMedGoogle Scholar
  8. 8.
    Travis CC, McClain TW, Birkner PD (1991) Diethylnitrosamine-induced hepatocarcinogenesis in rats: a theoretical study. Toxicol Appl Pharmacol 109:289–304PubMedGoogle Scholar
  9. 9.
    Cuenod C, Leconte I, Siauve N, Frouin F, Dromain C, Clement O, Frija G (2002) Deconvolution technique for measuring tissue perfusion by dynamic CT: application to normal and metastatic liver. Acad Radiol 9:S205–S211CrossRefPubMedGoogle Scholar
  10. 10.
    Idee J, Port M, Robert P, Raynal I, Prigent P, Dencausse A, Le Greneur S, Tichkowsky I, Le Lem G, Bourrinet P, Mugel T, Benderbous S, Devoldere L, Bourbouze R, Meyer D, Bonnemain B, Corot C (2001) Preclinical profile of the monodisperse iodinated macromolecular blood pool agent P743. Invest Radiol 36:41–49CrossRefPubMedGoogle Scholar
  11. 11.
    Wiart M, Corot C, Berthezene Y, Violas X, Canet E (2001) CT pulmonary angiography with a macromolecular contrast medium: a comparative study versus iobitridol in rabbits. Invest Radiol 36:547–553CrossRefPubMedGoogle Scholar
  12. 12.
    Conway JG, Popp JA, Thurman RG (1985) Microcirculation of hepatic nodules from diethylnitrosamine-treated rats. Cancer Res 45:3620–3625PubMedGoogle Scholar
  13. 13.
    Materne R, Annet L, Dechambre S, Sempoux C, Smith AM, Corot C, Horsmans Y, Van Beers BE (2002) Dynamic computed tomography with low- and high-molecular-mass contrast agents to assess microvascular permeability modifications in a model of liver fibrosis. Clin Sci 103:213–216PubMedGoogle Scholar
  14. 14.
    Yamamoto T, Kaneda K, Hirohashi K, Kinoshita H, Sakurai M (1996) Sinusoidal capillarization and arterial blood supply continuously proceed with the advance of the stages of hepatocarcinogenesis in the rat. Jpn J Cancer Res 87:442–450PubMedGoogle Scholar
  15. 15.
    Yamaguchi R, Yano H, Nakashima Y, Ogasawara S, Higaki K, Akiba J, Hicklin DJ, Kojiro M (2000) Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues. Oncol Rep 7:725–729PubMedGoogle Scholar
  16. 16.
    Yamaura H, Sato H (1974) Quantitative studies on the developing vascular system of rat hepatoma. J Natl Cancer Inst 53:1229–1240PubMedGoogle Scholar
  17. 17.
    Kojiro M, Nakashima O (1999) Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis 19:287–296PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Laure S. Fournier
    • 1
  • Charles Andre Cuenod
    • 1
  • Cedric de Bazelaire
    • 1
  • Nathalie Siauve
    • 1
  • Christophe Rosty
    • 2
  • Phuong Lan Tran
    • 3
  • Guy Frija
    • 1
  • Olivier Clement
    • 1
  1. 1.Laboratoire de Recherche en Imagerie, INSERM U494Necker InstituteParisFrance
  2. 2.Department of PathologyHopital Europeen Georges PompidouParisFrance
  3. 3.INSERM U370Necker InstituteParisFrance

Personalised recommendations